# Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO

> **NCT05045885** · — · COMPLETED · sponsor: **Hamad Medical Corporation** · enrollment: 32 (actual)

## Conditions studied

- COVID-19 Pneumonia
- Extracorporeal Membrane Oxygenation Complication
- Tracheostomy Complication
- Respiratory Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05045885
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-12-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045885, "Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05045885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*